retatrutide phase 3 results Lilly's triple agonist achieves 16.8% weight loss in trial VisualAbstract: Retatrutide reduces body weight

Patients who adopt smaller meal sizes, focus on protein and fiber-rich foods, and eat slowly during their first two weeks typically report 4050% less abdominal discomfort compared to those who maintain their pre-treatment eating patterns

CrossRef From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players Avilene Rodrguez-Lara, Ascensin Rueda-Robles, Mara Jos Sez-Lara, Julio Plaza-Diaz, Ana I

Diabetologia 55 , 24452455 (2012)

This is most likely a result of GLP-1 receptor agonists producing the desired effect, weight loss, as opposed to a direct effect of GLP-1 receptor agonists on reduced gallbladder emptying or suppression of cholecystokinin, which has been hypothesized

With the right choices, youll protect your muscles, keep your energy up, and make every bite count while GLP-1s do their job

We will track your progress to ensure your weight loss is healthy and safe